Good morning everyone, with the increase in the number of patients who have been successfully treated with new coronary pneumonia, experts have found that the plasma of patients in the recovery stage helps other patients to overcome the disease, let’s see what’s going on:

Call on patients in recovery to donate plasma

@ 上海 新闻 【 Wuhan President of Jinyintan Hospital: Patients are requested to donate plasma after rehabilitation ] Hubei Provincial New Crown Pneumonia Epidemic Prevention and Control Headquarters held a press conference at 21:00 on the 13th, inviting experts from the Central Steering Group Medical Treatment Team and vice president of Beijing Chaoyang Hospital Tong Zhaohui, Captain of the Medical Team of Guangzhou Support Wuhan Union Hospital, Zhang Nufu, Deputy Dean of the First Affiliated Hospital of Guangzhou Medical University, and Zhang Dingyu, Dean of Wuhan Jinyintan Hospital, introduced the progress of critical care in Wuhan and answered questions from reporters.

Zhang Dingyu, the director of Wuhan Jinyintan Hospital, said at the meeting that the hospital is in the process of transfusion of recovery patients’ plasma and has shown initial results. There are a large number of integrated antibodies against the virus in the recovered patients. I hereby urge the patients who have recovered to actively come to the hospital, extend their arms, donate plasma, and jointly rescue the patients who are still struggling with the disease.

Therapeutic new crown special free plasma products are put into clinical practice

@dale Finance [ Treatment Sexual new crown free plasma products have been put into clinical use: patients’ key indicators have improved, clinical signs and symptoms have improved. ] Recently, Sinopharm Biocommunity has completed the collection of plasma from some recoverers, launched new crown virus free plasma products and Preparation of exoglobulin. After rigorous blood biosafety testing, virus inactivation, and antiviral activity testing, special immune plasma has been successfully prepared for clinical treatment. It has been used in China Biological Wuhan Institute of Biological Products, Sinopharm Wuhan Blood Products Co., Ltd., Wuhan The First People’s Hospital of Jiangxia District, Wuhan Blood Center, Wuhan Institute of Virology, Chinese Academy of Sciences, and the China Food and Drug Testing Institute have been working closely to provide clinical care for critically ill patients.

On February 8th,New Coronavirus-infected pneumonia diagnosis and treatment plan (trial version 5) is used as a guide. In the first phase of the first people’s hospital in Jiangxia District, three new patients were treated with new crown-free plasma, and together with subsequent hospitals, more than 10 critical patients were treated. people. Clinically, after 12 to 24 hours of treatment, the main inflammatory indicators in the laboratory decreased significantly, the proportion of lymphocytes increased, key indicators such as blood oxygen saturation and viral load improved, and clinical signs and symptoms improved significantly.

New Crown Free Immunoplasm Products are plasma prepared by high-valence New Crown Virus specific antibodies donated by ex-patients. They are processed by virus inactivation, and are tested against new Crown Virus neutralizing antibodies and multiple pathogenic microorganisms. Treatment of critically ill patients with new coronary pneumonia.

14840 new cases of new pneumonia in Hubei

@ 彭湃 新闻 【 14840 new cases of new coronary pneumonia in Hubei, including 13332 clinical diagnosis < / a>] On February 12, 2020, from 04:00 to 24:00, Hubei Province newly added 14,840 new cases of pneumonia (including 13332 clinically diagnosed cases). As of 24:00 on February 12, 2020, Hubei Province has reported a total of 48206 cases of new coronary pneumonia (including 13332 clinically diagnosed cases), a total of 3441 cases were discharged from the hospital, and a total of 1310 patients were hospitalized. Currently, 33693 is still being treated in hospital. example.

The national mask capacity utilization rate reached 94%

@ 新京报 【 National Development and Reform Commission : As of the 11th, the national mask production capacity utilization rate reached 94% ] The State Council ’s joint defense and joint control machine is scheduled to hold a press conference at 15:00 on February 13th to introduce the latest progress in the protection of important medical supplies and the deployment of medical resources. At the press conference, Xia Nong, a first-level inspector of the Industrial Development Department of the National Development and Reform Commission, said that since February 2, China’s mask output has been increasing day by day. As of February 11, the national mask capacity utilization rate reached 94%, and the medical N95 mask capacity utilization rate reached 128%. Hubei masks Nissan 45,000 from the 2nd